KELSIE ROHR: Open Payments
NPI 1316473663 · DAYTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$692 in 75 payments from 3 companies in 2025. Trend: 2023 $279 · 2024 $535 · 2025 $692
Food & beverage: $692
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 59 | $502 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $140 |
| Novo Nordisk Inc | 3 | $50 |
Products named: VRAYLAR, CAPLYTA, QULIPTA, UBRELVY, Ozempic.
Industry payments across OH — which companies pay providers there.
